Article
Genomic characterization of a vancomycin-intermediate Staphylococcus aureus (VISA) small colony variant after long-term antibiotic therapy.
Journal of global antimicrobial resistance - 1 Jun 2026
Urushibara Noriko, Aung Meiji Soe, Sakurada Minoru, Kaji Kentaro, Sakai Yoshiyuki, Kobayashi Nobumichi
Abstract excerpt
OBJECTIVES: Vancomycin (VCM)-intermediate Staphylococcus aureus (VISA) and small-colony variants (SCVs) are clinically important phenotypes that are frequently difficult to treat and commonly encountered in persistent or recurrent infections. We previously reported a VISA strain, HV2019-1, isolated during a relapse episode of pacemaker-associated bloodstream infection. In the present study, we further...
Topics
Join the communities discussing this publication.
